title: Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.
authors.forename: J
authors.initials: J
authors.lastname: Hirsh
authors.forename: E W
authors.initials: EW
authors.lastname: Salzman
authors.forename: L
authors.initials: L
authors.lastname: Harker
authors.forename: V
authors.initials: V
authors.lastname: Fuster
authors.forename: J E
authors.initials: JE
authors.lastname: Dalen
authors.forename: J A
authors.initials: JA
authors.lastname: Cairns
authors.forename: R
authors.initials: R
authors.lastname: Collins
mesh_terms: D001241:Aspirin / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D004176:Dipyridamole / Q000494:pharmacology; D011464:Epoprostenol / Q000096:biosynthesis; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D013272:Stomach Diseases / Q000139:chemically induced; D013928:Thromboxane A2 / Q000096:biosynthesis
chemical_list: D010975:Platelet Aggregation Inhibitors; D013928:Thromboxane A2; D004176:Dipyridamole; D011464:Epoprostenol; D001241:Aspirin